FMP

FMP

Enter

SVRA - Savara Inc.

Terminal Value of Savara Inc.(SVRA), Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its l

photo-url-https://financialmodelingprep.com/image-stock/SVRA.png

Savara Inc.

SVRA

NASDAQ

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

3.87 USD

-0.21 (-5.43%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep